Clinical trial

FitEx for Endometrial Cancer Survivors: Initial Efficacy

NCT05737745

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-02-01

PhaseNA

Study timeline

Study start (actual)2023-02-01Date precision: day

Registry last updated2025-05-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Endometrial Cancerunresolved

Obesityunresolved

Sedentary Behaviorunresolved

Quality of Lifeunresolved

Survivorshipunresolved

Interventions

Self-monitoringBEHAVIORAL

Group-dynamicsBEHAVIORAL

Weekly virtual sessions- StandardBEHAVIORAL

Newsletters- StandardBEHAVIORAL

Newsletters- YogaBEHAVIORAL

Weekly virtual sessions- YogaBEHAVIORAL

Sponsors & collaborators

Carilion Cliniclead sponsor

National Institutes of Health (NIH)collaborator

National Center for Advancing Translational Sciences (NCATS)collaborator

Virginia Polytechnic Institute and State Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05737745 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.